Filing Details
- Accession Number:
- 0001209191-20-031697
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 16:10:35
- Reporting Period:
- 2020-05-20
- Accepted Time:
- 2020-05-22 16:10:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1725057 | Ceridian Hcm Holding Inc. | CDAY | Services-Prepackaged Software (7372) | 463231686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733807 | Arthur Gitajn | C/O Ceridian Hcm Holding Inc. 3311 East Old Shakopee Road Minneapolis MN 55425 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-20 | 26,000 | $16.82 | 38,591 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-20 | 60,500 | $22.00 | 99,091 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-20 | 77,282 | $65.45 | 21,809 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-20 | 9,218 | $66.05 | 12,591 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2020-05-20 | 26,000 | $0.00 | 26,000 | $16.82 |
| Common Stock | Option (right to buy) | Disposition | 2020-05-20 | 60,500 | $0.00 | 60,500 | $22.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 112,500 | 2026-12-31 | No | 4 | M | Direct | |
| 123,565 | 2028-04-25 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | $44.91 | 2029-02-08 | 3,048 | 3,048 | Direct | |
| Common Stock | Option (right to buy) | $49.93 | 2029-03-20 | 114,503 | 114,503 | Direct | |
| Common Stock | Performance Units | $0.00 | 2021-03-01 | 1,632 | 1,632 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-02-08 | 3,048 | 3,048 | Direct |
| 2029-03-20 | 114,503 | 114,503 | Direct |
| 2021-03-01 | 1,632 | 1,632 | Direct |
Footnotes
- The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018, and amended on November 20, 2018.
- Includes (i) 11,627 shares of common stock, (ii) 964 shares are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.87 to $65.85 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.88 to $66.32 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Consists of 26,000 vested and exercisable options as of December 31, 2019, of which 26,000 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 112,500 options that vest and become exercisable on December 31, 2020.
- Not applicable.
- Consists of 61,782 vested and exercisable options as of April 25, 2020, of which 60,500 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 122,283 options that vest and become exercisable in two annual installments beginning on April 25, 2021.
- Consists of 762 vested and exercisable options as of February 8, 2020 and 2,286 options that vest and become exercisable in three annual installments beginning on February 8, 2021.
- Consists of 28,625 vested and exercisable options as of March 20, 2020 and 85,878 options that vest and become exercisable in three annual installments beginning on March 20, 2021.
- Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.
Billionaire Hedge Funds
